PLASMA-LEVELS OF ATRIAL-NATRIURETIC-FACTOR (ANF) AND URINARY-EXCRETION OF ANF, ARGININE-VASOPRESSIN AND CATECHOLAMINES IN CHILDREN WITH CONGENITAL HEART-DISEASE - EFFECT OF CARDIAC-SURGERY

被引:16
作者
AGNOLETTI, G
SCOTTI, C
PANZALI, AF
CECONI, C
CURELLO, S
ALFIERI, O
MARZOLLO, P
BINI, R
ALBERTINI, A
FERRARI, R
机构
[1] Cattedra di Cardiologia, Universiti di Brescia
[2] Cattedra di Chimica Applicata alle Scienze Biomediche, Universita di Brescia
关键词
ATRIAL NATRIURETIC PEPTIDE; ANTIDIURETIC HORMONE; CONGENITAL HEART DISEASE;
D O I
10.1016/1010-7940(93)90052-D
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We studied the changes in the plasma concentration of atrial natriuretic factor (ANF) and the urinary excretion of ANF, arginine vasopressin (AVP) and catecholamines in 22 children with congenital heart disease, divided into two groups. Group 1 included 11 children with congestive heart failure (CHF), treated with digitalis and diuretics. Group 2 included 11 children without CHF and without medical treatment. Each group was compared with a control group of 15 healthy, age-matched children. The plasma concentration of ANF was raised in both groups, but it was significantly higher in group 1 (235.5 +/- 82.9 pg/ml), compared to group 2 (48.4 +/- 29.4 pg/ml, P < 0.002). Urinary excretion of ANF was measurable in both groups and higher in group 1 (185.9 +/- 116.2 pg/kg per h) than in group 2 (48.5 +/- 30.7 pg/kg per h), but not significantly so. Urinary excretion of AVP and catecholamines was not different in children with congenital heart disease and healthy children. Twenty-four hours after surgery, plasma ANF diminished in group 1 (from 235.5 +/- 82.9 to 93.4 +/- 53.8 pg/ml, P < 0.003), but did not change in group 2. The urinary excretion of ANF was unchanged in both groups. In contrast, urinary excretion of AVP and catecholamines rose significantly in both groups. These data show that plasma ANF is increased in children with congenital heart disease, even in the absence of CHE The measurement of urinary ANF is less reliable than a plasma assay. The postoperative increases in AVP and catecholamine urinary excretions could be responsible for the vasoconstriction and water retention typical of the postoperative period.
引用
收藏
页码:533 / 539
页数:7
相关论文
共 39 条
  • [1] Agnoletti G., Cornacchiari A., Panzali A.F., Ghielmi S., De Giuli F., Ferrari R., Effect of congestive heart failure on rate of atria1 natriuretic factor release in response to stretch and isoprenaline, Cardiovasc Res, 249, pp. 38-945, (1990)
  • [2] Akimoto K., Miyata A., Kangawa K., Plasma and riaht auricle concentrations of atria1 natriuretic polypeptide in ciildren with cardiac diseases, Eur J Pediatr, 147, pp. 485-489, (1988)
  • [3] Anand I.S., Ferrari R., Kalra G.S., Wahi P.L., Poole-Wilson P.A., Harris P.C., Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure, Circulation, 80, pp. 299-305, (1989)
  • [4] Andersson S., Tikkanen I., Pesonen E., Wallgren E.I., Fyrquist F., Atria1 natriuretic peptide and atria1 pressure in newborns with transposition of the great arteries, Acta Paediatr Stand, 77, pp. 72-75, (1988)
  • [5] Bates E.R., Shenker Y., Grenkin R.J., The relationship between plasma levels of immunoreactive atria1 natriuretic hormone and hemodynamic function in man, Circulation, 73, pp. 1155-1161, (1986)
  • [6] Burch M., Shinebourne E.A., Rigby M.L., Plasma atria1 natriuretic peptide after Fontan procedure and total cavopulmonary connection, Int J Cardiol, 27, pp. 161-165, (1990)
  • [7] Curello S., Ceconi C., De Giuli F., Time-course of human atria1 natriuretic factor release during cardiopulmonary bypass in mitral valve and coronary artery diseased patients, Eur J Cardio-Thorac Surg, 5, pp. 205-210, (1991)
  • [8] Drexler H., Hanze J., Finckh M., Lu W., Just H., Lang R.E., Atria1 natriuretic peptide in a rat model of cardiac failure. Atria1 and ventricular mRNA, atria1 content, plasma levels, and effect of volume loading, Circulation, 79, pp. 620-633, (1989)
  • [9] Ferrari R., Ceconi C., Signorini C., Anand I.S., Harris P.C., Alber-Tini A., Sample treatment for long-distance transport of plasma for hormone assay, Clin Chem, 35, pp. 331-332, (1989)
  • [10] Francis G.S., Benedict C., Johnstone D.E., Comparison of neuroendocrine activation in patients with left ventricular dys function with or without congestive heart failure, Circulation, 82, pp. 1724-1729, (1990)